The etiopathogenesis of burning mouth syndrome (BMS) seems to be complex and many patients probably involves interactions among local, systemic, and/or psychological factors in the pathophysiologic mechanism. Although there are controversies over whether the psychological factor is a cause or a result of BMS, several studies have supported strong relationships between psychological factors and chronic pain. It has been suggested that somatic complaints from unfavorable life experiences may influence both individual personality and mood changes; however, initiation of BMS symptoms is not necessarily correlated with stressful life events despite their elevated psychological stress. If the psychological distress is not a causal factor of BMS, it seems that BMS patients may be particularly vulnerable to psychological problems, primarily depression, anxiety, and hostility due to the characteristic entities of BMS such as chronic persistent pain itself. It seems likely that both physiological and psychological factors play a role in causing, perpetuating and/or exacerbating BMS; therefore, both two components of the patient's symptoms must be addressed. The acceptance of psychological factors by the patient is often an important element of BMS, management. The evaluation of psychological and emotional status of BMS patient enables clinicians to recognize prolonged negative and subclinical factors which can complicate the management of pain or indirectly perpetuate other physical factors. This evaluation improves the doctor-patient relationships, motivation, and compliance through a correct understanding of the clinical problem. Appropriate emotional and psychological evaluation may be required prior to developing a treatment plan in order to gain the successful treatment outcome.
INTRODUCTION
Burning mouth syndrome (BMS) has been defined as a burning pain in the tongue or oral mucous membranes, usually without accompanying clinical and laboratory findings. 1, 2) It has variously been termed as glossodynia, glossopyrosis, stomatodynia, or oral dysesthesia. Its symptoms usually include oral burning sensation, dry mouth, altered taste perception, irritability, changes in diet, and lowering classified into three types according to the clinical oral pain pattern. 16 ) Type 1 BMS is characterized by a pain-free waking, with burning sensation developing in the late morning, gradually increasing in severity during the day, and reaching its peak intensity by evening. This type affects approximately 35% of patients and is linked to systemic disorders such as nutritional deficiency, diabetes mellitus, etc. Type 2 consists of continuous symptoms throughout the day.
Patients find it difficult to get to sleep and this type occurs in about 55% of patients. Type 3 BMS is characterized by intermittent symptoms with pain-free periods during the day. Frequently, these patients constitute 10% of total patients and show allergic reaction. 16, 17) Especially, type 2 BMS which accounts for more than half of all diagnosed BMS is usually associated with psychological disorders and patients with type 2 tend to be most resistant to therapy.
18)

Severity and Duration of BMS Symptoms
A psychological component in BMS patients has been continuously suggested in numerous studies. For example, there are alterations in personality traits and mood changes consist of different grades of anxiety and depression, decreased aptitude to socialization, dizziness, psychasthenia, excessive concern about health, too many sad thoughts, and reluctance to take the initiative. Neuroticism is the only personality dimension that is significantly correlated to severity of burning sensation, so they can be indicators for the severity of BMS symptoms. 19) This result is in line with the findings of Grushka et al. 20) who compared the pain experience and the personality profile of BMS patients. They also found that BMS patients scored higher at personality characteristic scales as the pain increases.
These psychological disorders seem to be independent of symptom intensity, but appear to be mostly related to the Pokupec-Gruden et al. 13) verified in a case-controlled study that anxiety and depression are most common in patients with BMS.
Amenábar et al. 14) also found higher scores of anxiety and salivary cortisol levels in patients with BMS than in control subjects.
According to these studies, psychological abnormalities such as personality disorders, emotional instability, socially isolated, introverted, low self-esteem, prone to worry, nervous and tense, neuroticism, vulnerability, negative affect, lower life satisfaction, excessive concern about health, too many sad thoughts, obsession-compulsion, personal sensitivity, and psychoticism are associated with BMS. In particular, the level of anxiety, depression, and symptoms of somatization, and frequency of adverse life events in patients with BMS were higher than those of the control group.
15)
Psychological Association with BMS Subtypes
It has been suggested that patients with BMS may be Bogetto et al. 9) studied psychiatric comorbidity in patients with BMS. In the relation between life events and BMS during a period of 6 months before the onset of BMS symptoms, no significant difference was found between BMS patients and the control group. They concluded the severity of life events, rather than in their number, was significantly associated with BMS. Although BMS patients are subjected to elevated psychological stress, the initiation of BMS symptoms is not necessarily correlated with stressful life events. 12) However, this result is certainly not a universal finding and there is often a temporal relationship between such events and BMS symptom. 
Causal Relationship
The possible etiologic role of psychogenic causes of the burning sensation is widely discussed in the literatures, however, it does not determined clearly yet. 1, [8] [9] [10] There is no significant difference between BMS patients and controls with respect to various physiological factors. 11, 12, 26, 29, 30) The only significant differences were found in self-reported depression and anxiety in case control study. 31) Hakeberg et al. 26) proved that the appearance of the BMS was preceded by an acutely stressful event. Most of these literatures, however, were anecdotal, and only a few studies used objective psychometric methods to assess the patient's psychological status.
Bogetto et al. 9) studied on the psychiatric comorbidity in the BMS patients. Although in most patients the onset of treatment. 8, 17) Mood changes consist of different grades of anxiety and depression, which often result in an extremely poor quality of life. 17) 4. Cancerphobia
Patients with BMS are 2.7 times more likely to display a cancerphobia than controls. 21) Cancerphobia is present in 20%-30% of BMS patiens. 22) The BMS patients may be concerned that the symptoms are caused by oral or tongue cancer, although the patient rarely shares this concern spontaneously with the physician.
BMS patients associated with hypochondria and other phobias represent a poor prognosis. In particular, these patients may experience higher levels of pain, anxiety, and depression. 23) Reassurance that oral cancer is not present should be addressed clearly and repeatedly. In some cases, reassurance alone was often successful in alleviating the symptoms. Repeated reassurance and direct questioning of their fears are important, and occasionally clinician has resorted to medication to break the vicious cycle.
24)
Adverse Life Events
Some patients complain of BMS symptoms after the occurrence of the adverse life events; death of a close relative, poor adaptation to school and/or work, family or marital strife, financial problems, cancer diagnosis, etc. In some cases dental procedures may be the adverse experiences under certain conditions. ties. There were no differences between two groups with respect to pain duration, pain intensity, life interference, and levels of psychological distress. Accompanying mood and sleep disturbances and depression may be reactive and secondary to BMS or to other menopausal stresses.
36)
The usefulness of tricyclic antidepressants and some benzodiazepines may be more closely related to their analgesic and anticonvulsant properties, and to the possible effect of benzodiazepines on taste-pain pathways. 29) The reported success of psychotherapies in the treatment of BMS may be related more to an improvement in ability to cope with their suffering and emotional distress than to a "cure" of the disorder.
29)
These two conflicting opinions could be due to experimenter expectancies when assessors were not blind to the subject's diagnostic status, inaccurate diagnosis and classification of BMS patients themselves, different psychological assessment instruments, or comparisons between group norms rather than against a clinical standard. In particular, determinations regarding levels of depression and anxiety are based more often either on mean differences between groups on self-report measures, or on a subjective psychiatric diagnosis based on a clinical interview. These psychological problems are also typical of many other chronic or long term diseases and it is difficult to establish the cause and effect relationship. Bergdahl et al. 33) found that the pain intensity of BMS was significantly reduced in the CT group directly after CT was completed and was further reduced in a 6-month follow-up. Placebo group did not show any decrease in pain intensity of BMS.
Another aspect that has to be taken into consideration in the psychological treatment of BMS is that many patients also fail to understand that the response to the treatment is obtained only after a specified minimum period of treatment. In general the patients want quick and effective solutions for their disease. In such cases, the resistance to accept psychotherapy is even greater. Thus, in order to change this situation, the group psychotherapy can be proposed. It was intended to build the confidence of the patients in health professionals. In the group therapy patients shared information about their symptoms and fear, e.g., cancer phobia. This is a simple form of therapy which helps to avoid the isolation and loneliness of the patients. When in a group they also improved their knowledge about the disease and established a fundamental change to accept any proposed treatment. 42 However, to regard BMS as merely a somatic symptom of an underlying psychiatric disorder is inappropriate. 
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